SSCI Meeting Highlights: Oxidative Stress and Cardiology Injury SymposiumOxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant Therapy
Section snippets
ATHEROMA FORMATION
The first step in atherogenesis is the formation of fatty streaks, which are small subendothelial deposits of monocyte-derived macrophages rich in ox-LDL. Ox-LDL is taken up by specialized receptors on endothelial cells and induces endothelial activation and injury.3 The initial damage to endothelial cells by ox-LDL results in the expression of adhesion molecules leading to recruitment of monocyte and their migration to subendothelial layers. These monocytes differentiate into macrophages in
FORMATION OF OX-LDL
Ox-LDL is a more potent pro-atherosclerotic mediator than native unmodified LDL.4 Several reactive oxygen species (ROS) can initiate lipid peroxidation leading to activation of native unmodified LDL resulting in the formation of ox-LDL. These include reactions involving multiple enzyme systems like nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (generates superoxide anion),5 mitochondrial electron transport enzymes,6 xanthine oxidase,7 lipoxygenase,8 cyclooxygenase,9
OX-LDL AND ATHEROSCLEROSIS
Ox-LDL plays a central proatherogenic role in the arterial wall13., 14., 15. (Table 1; Figure 1). Kita et al35 established the importance of ox-LDL in atherosclerosis by using antioxidant probucol in atherosclerosis-prone hyperlipidemic Wanatable heritable hyperlipidemic rabbits. This study showed the significance of oxidative state in atherogenesis. Now, it is well known that ox-LDL–induced pro-oxidant state is present in all stages of atherosclerosis from beginning to the acute thrombotic
ROLE OF LOX-1 IN ATHEROGENESIS
Ox-LDL acts via binding to a number of scavenger receptors (SR), such as SR-A1, SR-A2 and LOX-1. Lately, LOX-1, a type II membrane protein ox-LDL receptor with a C-type lectin-like extracellular domain and a short cytoplasmic tail has gained much importance in the effects of ox-LDL on endothelial biology because these cells primarily express LOX-1 as receptor for ox-LDL.16., 38., 39. This receptor was initially identified in endothelial cells, but later was also found to be expressed in
INTERACTION BETWEEN OX-LDL AND ANG II
Both Ang II and ox-LDL are important factors in inducing endothelial dysfunction and injury. Ang II, which is highly expressed in the growing atheroma, shares many of the properties of ox-LDL (Table 2; Figure 1). The effects of Ang II seem to be mediated by activation of its type 1 receptor (AT1R).61 There is ample experimental evidence that ox-LDL upregulates AT1R mRNA via NADPH oxidase-mitogen-activated protein kinase-nuclear factor-kappaB pathway and that Ang II in a positive feedback
Angiogenesis
There is much interest in the process of angiogenesis in atherosclerosis that may have important clinical consequences. Dandapat et al24 showed that small concentrations of ox-LDL (<5 μg protein/mL) promote capillary tube formation by inducing low levels of ROS release via LOX-1–mediated activation of NADPH oxidase-mitogen-activated protein kinases-nuclear factor-kappaB-vascular endothelial growth factor pathway. Progressive angiogenesis in a primary atherosclerotic lesion may cause plaque
EVIDENCE OF OXIDATIVE STRESS IN HUMANS
A host of studies have shown evidence for increased oxidant stress in all risk factors for atherosclerosis, including diabetes mellitus, hypertension, dyslipidemia, smoking, hyperhomocysteinemia and obesity.2., 75., 76. Here, we mention some of the studies that indicate increased oxidant load in these patients:
- 1.
There is increased oxidation of LDL-cholesterol in subjects with subclinical or clinical atherosclerosis.
- 2.
The ox-LDL levels in serum are increased in patients with ischemic heart disease
USE OF ANTIOXIDANTS IN HUMANS
Numerous cellular antioxidant systems exist to defend against the oxidant stress and to maintain the normal redox balance of cells in our body. ROS are cleared from cells by enzymatic and nonenzymatic systems. Enzymatic systems include superoxide dismutases,87., 88. catalase88 and glutathione peroxidase.89., 90. The nonenzymatic systems include alpha tocopherol (vitamin E), ascorbic acid (vitamin C), glutathione and uric acid. Because ROS are widely involved in progression of atherosclerosis,
WHY HAVE ANTIOXIDANT STRATEGIES FAILED IN HUMANS?
The reasons for the absence of the beneficial effects of antioxidants in disease states related to atherosclerosis are many-fold and essentially unknown. Some of the following may be plausible reasons for the absence of beneficial effect:
- 1.
Antioxidants may need to be used for long time for the desired effects to be manifest.
- 2.
Antioxidants may need to be given before the disease process starts or becomes established.
- 3.
Antioxidants, such as vitamin E, may become oxidized and lose their efficacy as
CONCLUSIONS ON THE ROLE OF OXIDATION HYPOTHESIS IN ATHEROGENESIS
Oxidant load, present in coronary artery disease risk factors, induces adverse effects on different cells of arterial walls resulting in atherosclerosis. Oxidant species oxidize n-LDL, and ox-LDL acts on cells of the arterial wall via LOX-1 and other scavenger receptors. Oxidant species and ox-LDL transform monocytes into macrophages and then foam cells. ROS also induce platelet activation, a common event in the precipitation of an ischemic event. Accordingly, ROS inhibitory strategies may be
REFERENCES (92)
- et al.
Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases
J Diabetes Complications
(2002) Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis
Atherosclerosis
(1998)- et al.
Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?
Atherosclerosis
(2006) Vascular cytochrome p450 enzymes: physiology and pathophysiology
Trends Cardiovasc Med
(2008)- et al.
Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders
Free Radic Biol Med
(2011) - et al.
Identification and autoregulation of receptor for ox-LDL in cultured human coronary artery endothelial cells
Biochem Biophys Res Commun
(1998) - et al.
The binding of oxidized low density lipoprotein (oxLDL) to oxLDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide
J Biol Chem
(2001) - et al.
Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36
J Biol Chem
(1997) - et al.
The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin
Biochem Pharmacol
(1999) - et al.
Stimulation of smooth muscle cell proliferation by ox-LDL- and acetyl LDL-induced macrophage-derived foam cells
Life Sci
(2001)
Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix
Vascul Pharmacol
Regulation of cell growth by oxidized LDL
Free Radic Biol Med
Oxidized LDL induces apoptosis in cultured smooth muscle cells: a possible role for 7-ketocholesterol
Biochem Biophys Res Commun
Activation-dependent surface expression of LOX-1 in human platelets
Biochem Biophys Res Commun
Identification of differentially expressed genes induced by transient ischemic stroke
Brain Res Mol Brain Res
Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE)
FEBS Lett
Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats
Biochem Biophys Res Commun
Angiotensin II receptor subtypes and biological response in the rat heart
J Mol Cell Cardiol
Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan
Atherosclerosis
Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina
Am Heart J
Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
J Am Coll Cardiol
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Lancet
Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome—comparison with other biomarkers
J Cardiol
Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable angina pectoris
Am J Cardiol
Superoxide dismutase and catalase inhibit oxidized low-density lipoprotein-induced human aortic smooth muscle cell proliferation: role of cell-cycle regulation, mitogen-activated protein kinases, and transcription factors
Atherosclerosis
Coronary heart disease epidemiology in the 21st century
Epidemiol Rev
Atherosclerosis—an inflammatory disease
N Engl J Med
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology
Physiol Rev
Mitochondrial dysfunction in atherosclerosis
Circ Res
Physiological roles of xanthine oxidoreductase
Drug Metab Rev
Lipoxygenase pathways as mediators of early inflammatory events in atherosclerosis
Arterioscler Thromb Vasc Biol
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study
Clin Pharmacol Ther
Oxidized LDL mediates the release of fibroblast growth factor-1
Arterioscl Thromb Vasc Biol
LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells
Circulation
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Circ Res
Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB
Circulation
Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors
Arterioscler Thromb Vasc Biol
Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells
Circulation
Transforming growth factor-beta(1) modulates oxidatively modified LDL-induced expression of adhesion molecules: role of LOX-1
Circ Res
LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells
Arterioscler Thromb Vasc Biol
Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells
Am J Physiol Endocrinol Metab
Small concentrations of ox-LDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway
Arterioscler Thromb Vasc Biol
Endocytosis of oxidized LDL and reversibility of migration inhibition in macrophage-derived foam cells in vitro. A mechanism for atherosclerosis regression?
Arterioscler Thromb
Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, and viability and nitric oxide synthesis
J Nutr
Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability
Expert Rev Cardiovasc Ther
Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling
J Pharmacol Exp Ther
Cited by (180)
Macrophage scavenger receptor A1 antagonizes abdominal aortic aneurysm via upregulating IRG1
2023, Biochemical PharmacologyNatural essential oils: A promising strategy for treating cardio-cerebrovascular diseases
2022, Journal of EthnopharmacologyPolyphenols and atherosclerosis: A critical review of clinical effects on LDL oxidation
2022, Pharmacological ResearchFocus on ferroptosis, pyroptosis, apoptosis and autophagy of vascular endothelial cells to the strategic targets for the treatment of atherosclerosis
2022, Archives of Biochemistry and Biophysics
Presented as a State-of-the-Art Lecture at the Southern Society for Clinical Investigation Cardiovascular Club Session, February 18, 2011, New Orleans, LA.